108 related articles for article (PubMed ID: 9772026)
1. Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?
Mecocci P; Cherubini A; Bregnocchi M; Chionne F; Cecchetti R; Lowenthal DT; Senin U
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):211-4. PubMed ID: 9772026
[TBL] [Abstract][Full Text] [Related]
2. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Blennow K; Wallin A; Agren H; Spenger C; Siegfried J; Vanmechelen E
Mol Chem Neuropathol; 1995 Dec; 26(3):231-45. PubMed ID: 8748926
[TBL] [Abstract][Full Text] [Related]
3. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
4. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Buerger K; Zinkowski R; Teipel SJ; Tapiola T; Arai H; Blennow K; Andreasen N; Hofmann-Kiefer K; DeBernardis J; Kerkman D; McCulloch C; Kohnken R; Padberg F; Pirttilä T; Schapiro MB; Rapoport SI; Möller HJ; Davies P; Hampel H
Arch Neurol; 2002 Aug; 59(8):1267-72. PubMed ID: 12164722
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.
Ishiguro K; Ohno H; Arai H; Yamaguchi H; Urakami K; Park JM; Sato K; Kohno H; Imahori K
Neurosci Lett; 1999 Jul; 270(2):91-4. PubMed ID: 10462105
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of tau in cerebrospinal fluid in alzheimer disease].
Hu Y; He S; Wang J
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1377-9. PubMed ID: 11930632
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
[TBL] [Abstract][Full Text] [Related]
10. Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.
Kurz A; Riemenschneider M; Buch K; Willoch F; Bartenstein P; Müller U; Guder W
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):372-7. PubMed ID: 9876968
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.
Andreasen N; Minthon L; Davidsson P; Vanmechelen E; Vanderstichele H; Winblad B; Blennow K
Arch Neurol; 2001 Mar; 58(3):373-9. PubMed ID: 11255440
[TBL] [Abstract][Full Text] [Related]
12. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
[TBL] [Abstract][Full Text] [Related]
13. [Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].
Arai H; Satoh K; Terajima M; Nakagawa T; Higuchi M; Kosaka Y; Zhu C; Sasaki H
Nihon Ronen Igakkai Zasshi; 1996 Sep; 33(9):669-75. PubMed ID: 8940864
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
16. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.
Hu YY; He SS; Wang X; Duan QH; Grundke-Iqbal I; Iqbal K; Wang J
Am J Pathol; 2002 Apr; 160(4):1269-78. PubMed ID: 11943712
[TBL] [Abstract][Full Text] [Related]
17. [Tau protein. A potential biological indicator for early detection of Alzheimer disease].
Buch K; Riemenschneider M; Bartenstein P; Willoch F; Müller U; Schmolke M; Nolde T; Steinmann C; Guder WG; Kurz A
Nervenarzt; 1998 May; 69(5):379-85. PubMed ID: 9629553
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O
Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792
[TBL] [Abstract][Full Text] [Related]
19. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M
J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
